アスパラギナーゼの世界市場見通し2023年-2029年

◆英語タイトル:Asparaginase Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書(MMG23FB2462)◆商品コード:MMG23FB2462
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2023年2月
◆ページ数:77
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のアスパラギナーゼ市場規模と予測を収録しています。・世界のアスパラギナーゼ市場:売上、2018年-2023年、2024年-2029年
・世界のアスパラギナーゼ市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のアスパラギナーゼ市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「大腸菌」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

アスパラギナーゼのグローバル主要企業は、Jazz Pharmaceuticals、Servier Pharmaceuticals、Medac GmbH、Kyowa Hakko Kirin、Qianhong Bio-pharma、Taj Pharmaceuticals、Mingxing Pharma、SL Pharma、United Biotechなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、アスパラギナーゼのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のアスパラギナーゼ市場:タイプ別、2018年-2023年、2024年-2029年
世界のアスパラギナーゼ市場:タイプ別市場シェア、2022年
・大腸菌、Erwinia chrysanthemi、ペグ化

世界のアスパラギナーゼ市場:用途別、2018年-2023年、2024年-2029年
世界のアスパラギナーゼ市場:用途別市場シェア、2022年
・急性リンパ性白血病、急性骨髄性白血病

世界のアスパラギナーゼ市場:地域・国別、2018年-2023年、2024年-2029年
世界のアスパラギナーゼ市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるアスパラギナーゼのグローバル売上、2018年-2023年
・主要企業におけるアスパラギナーゼのグローバル売上シェア、2022年
・主要企業におけるアスパラギナーゼのグローバル販売量、2018年-2023年
・主要企業におけるアスパラギナーゼのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Jazz Pharmaceuticals、Servier Pharmaceuticals、Medac GmbH、Kyowa Hakko Kirin、Qianhong Bio-pharma、Taj Pharmaceuticals、Mingxing Pharma、SL Pharma、United Biotech

*************************************************************

・調査・分析レポートの概要
アスパラギナーゼ市場の定義
市場セグメント
世界のアスパラギナーゼ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のアスパラギナーゼ市場規模
世界のアスパラギナーゼ市場規模:2022年 VS 2029年
世界のアスパラギナーゼ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのアスパラギナーゼの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のアスパラギナーゼ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:大腸菌、Erwinia chrysanthemi、ペグ化
アスパラギナーゼのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:急性リンパ性白血病、急性骨髄性白血病
アスパラギナーゼの用途別グローバル売上・予測

・地域別市場分析
地域別アスパラギナーゼ市場規模 2022年と2029年
地域別アスパラギナーゼ売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Jazz Pharmaceuticals、Servier Pharmaceuticals、Medac GmbH、Kyowa Hakko Kirin、Qianhong Bio-pharma、Taj Pharmaceuticals、Mingxing Pharma、SL Pharma、United Biotech
...

Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin’s lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system.
This report aims to provide a comprehensive presentation of the global market for Asparaginase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asparaginase. This report contains market size and forecasts of Asparaginase in global, including the following market information:
Global Asparaginase Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Asparaginase Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Asparaginase companies in 2022 (%)
The global Asparaginase market was valued at US$ 375.6 million in 2022 and is projected to reach US$ 415 million by 2029, at a CAGR of 1.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Asparaginase key players include Jazz Pharmaceuticals, Servier Pharmaceuticals, Medac GmbH, Kyowa Hakko Kirin, Qianhong Bio-pharma, etc. Global top five manufacturers hold a share about 95%. Asia-Pacific is the largest market, with a share about 48%, followed by North America and Europe, both have a share about 35 percent. In terms of product, Pegylated is the largest segment. And in terms of application, the largest application is Acute Lymphoblastic Leukemia, followed by Acute Myeloid Leukemia, etc.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Asparaginase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Asparaginase Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Asparaginase Market Segment Percentages, by Type, 2022 (%)
Escherichia Coli
Erwinia Chrysanthemi
Pegylated
Global Asparaginase Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Asparaginase Market Segment Percentages, by Application, 2022 (%)
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Global Asparaginase Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Asparaginase Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Asparaginase revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Asparaginase revenues share in global market, 2022 (%)
Key companies Asparaginase sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Asparaginase sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Jazz Pharmaceuticals
Servier Pharmaceuticals
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
SL Pharma
United Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Asparaginase, market overview.
Chapter 2: Global Asparaginase market size in revenue and volume.
Chapter 3: Detailed analysis of Asparaginase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Asparaginase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Asparaginase capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Asparaginase Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Asparaginase Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Asparaginase Overall Market Size
2.1 Global Asparaginase Market Size: 2022 VS 2029
2.2 Global Asparaginase Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Asparaginase Sales: 2018-2029
3 Company Landscape
3.1 Top Asparaginase Players in Global Market
3.2 Top Global Asparaginase Companies Ranked by Revenue
3.3 Global Asparaginase Revenue by Companies
3.4 Global Asparaginase Sales by Companies
3.5 Global Asparaginase Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Asparaginase Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Asparaginase Product Type
3.8 Tier 1, Tier 2 and Tier 3 Asparaginase Players in Global Market
3.8.1 List of Global Tier 1 Asparaginase Companies
3.8.2 List of Global Tier 2 and Tier 3 Asparaginase Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Asparaginase Market Size Markets, 2022 & 2029
4.1.2 Escherichia Coli
4.1.3 Erwinia Chrysanthemi
4.1.4 Pegylated
4.2 By Type – Global Asparaginase Revenue & Forecasts
4.2.1 By Type – Global Asparaginase Revenue, 2018-2023
4.2.2 By Type – Global Asparaginase Revenue, 2024-2029
4.2.3 By Type – Global Asparaginase Revenue Market Share, 2018-2029
4.3 By Type – Global Asparaginase Sales & Forecasts
4.3.1 By Type – Global Asparaginase Sales, 2018-2023
4.3.2 By Type – Global Asparaginase Sales, 2024-2029
4.3.3 By Type – Global Asparaginase Sales Market Share, 2018-2029
4.4 By Type – Global Asparaginase Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Asparaginase Market Size, 2022 & 2029
5.1.2 Acute Lymphoblastic Leukemia
5.1.3 Acute Myeloid Leukemia
5.2 By Application – Global Asparaginase Revenue & Forecasts
5.2.1 By Application – Global Asparaginase Revenue, 2018-2023
5.2.2 By Application – Global Asparaginase Revenue, 2024-2029
5.2.3 By Application – Global Asparaginase Revenue Market Share, 2018-2029
5.3 By Application – Global Asparaginase Sales & Forecasts
5.3.1 By Application – Global Asparaginase Sales, 2018-2023
5.3.2 By Application – Global Asparaginase Sales, 2024-2029
5.3.3 By Application – Global Asparaginase Sales Market Share, 2018-2029
5.4 By Application – Global Asparaginase Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Asparaginase Market Size, 2022 & 2029
6.2 By Region – Global Asparaginase Revenue & Forecasts
6.2.1 By Region – Global Asparaginase Revenue, 2018-2023
6.2.2 By Region – Global Asparaginase Revenue, 2024-2029
6.2.3 By Region – Global Asparaginase Revenue Market Share, 2018-2029
6.3 By Region – Global Asparaginase Sales & Forecasts
6.3.1 By Region – Global Asparaginase Sales, 2018-2023
6.3.2 By Region – Global Asparaginase Sales, 2024-2029
6.3.3 By Region – Global Asparaginase Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Asparaginase Revenue, 2018-2029
6.4.2 By Country – North America Asparaginase Sales, 2018-2029
6.4.3 US Asparaginase Market Size, 2018-2029
6.4.4 Canada Asparaginase Market Size, 2018-2029
6.4.5 Mexico Asparaginase Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Asparaginase Revenue, 2018-2029
6.5.2 By Country – Europe Asparaginase Sales, 2018-2029
6.5.3 Germany Asparaginase Market Size, 2018-2029
6.5.4 France Asparaginase Market Size, 2018-2029
6.5.5 U.K. Asparaginase Market Size, 2018-2029
6.5.6 Italy Asparaginase Market Size, 2018-2029
6.5.7 Russia Asparaginase Market Size, 2018-2029
6.5.8 Nordic Countries Asparaginase Market Size, 2018-2029
6.5.9 Benelux Asparaginase Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Asparaginase Revenue, 2018-2029
6.6.2 By Region – Asia Asparaginase Sales, 2018-2029
6.6.3 China Asparaginase Market Size, 2018-2029
6.6.4 Japan Asparaginase Market Size, 2018-2029
6.6.5 South Korea Asparaginase Market Size, 2018-2029
6.6.6 Southeast Asia Asparaginase Market Size, 2018-2029
6.6.7 India Asparaginase Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Asparaginase Revenue, 2018-2029
6.7.2 By Country – South America Asparaginase Sales, 2018-2029
6.7.3 Brazil Asparaginase Market Size, 2018-2029
6.7.4 Argentina Asparaginase Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Asparaginase Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Asparaginase Sales, 2018-2029
6.8.3 Turkey Asparaginase Market Size, 2018-2029
6.8.4 Israel Asparaginase Market Size, 2018-2029
6.8.5 Saudi Arabia Asparaginase Market Size, 2018-2029
6.8.6 UAE Asparaginase Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Jazz Pharmaceuticals
7.1.1 Jazz Pharmaceuticals Company Summary
7.1.2 Jazz Pharmaceuticals Business Overview
7.1.3 Jazz Pharmaceuticals Asparaginase Major Product Offerings
7.1.4 Jazz Pharmaceuticals Asparaginase Sales and Revenue in Global (2018-2023)
7.1.5 Jazz Pharmaceuticals Key News & Latest Developments
7.2 Servier Pharmaceuticals
7.2.1 Servier Pharmaceuticals Company Summary
7.2.2 Servier Pharmaceuticals Business Overview
7.2.3 Servier Pharmaceuticals Asparaginase Major Product Offerings
7.2.4 Servier Pharmaceuticals Asparaginase Sales and Revenue in Global (2018-2023)
7.2.5 Servier Pharmaceuticals Key News & Latest Developments
7.3 Medac GmbH
7.3.1 Medac GmbH Company Summary
7.3.2 Medac GmbH Business Overview
7.3.3 Medac GmbH Asparaginase Major Product Offerings
7.3.4 Medac GmbH Asparaginase Sales and Revenue in Global (2018-2023)
7.3.5 Medac GmbH Key News & Latest Developments
7.4 Kyowa Hakko Kirin
7.4.1 Kyowa Hakko Kirin Company Summary
7.4.2 Kyowa Hakko Kirin Business Overview
7.4.3 Kyowa Hakko Kirin Asparaginase Major Product Offerings
7.4.4 Kyowa Hakko Kirin Asparaginase Sales and Revenue in Global (2018-2023)
7.4.5 Kyowa Hakko Kirin Key News & Latest Developments
7.5 Qianhong Bio-pharma
7.5.1 Qianhong Bio-pharma Company Summary
7.5.2 Qianhong Bio-pharma Business Overview
7.5.3 Qianhong Bio-pharma Asparaginase Major Product Offerings
7.5.4 Qianhong Bio-pharma Asparaginase Sales and Revenue in Global (2018-2023)
7.5.5 Qianhong Bio-pharma Key News & Latest Developments
7.6 Taj Pharmaceuticals
7.6.1 Taj Pharmaceuticals Company Summary
7.6.2 Taj Pharmaceuticals Business Overview
7.6.3 Taj Pharmaceuticals Asparaginase Major Product Offerings
7.6.4 Taj Pharmaceuticals Asparaginase Sales and Revenue in Global (2018-2023)
7.6.5 Taj Pharmaceuticals Key News & Latest Developments
7.7 Mingxing Pharma
7.7.1 Mingxing Pharma Company Summary
7.7.2 Mingxing Pharma Business Overview
7.7.3 Mingxing Pharma Asparaginase Major Product Offerings
7.7.4 Mingxing Pharma Asparaginase Sales and Revenue in Global (2018-2023)
7.7.5 Mingxing Pharma Key News & Latest Developments
7.8 SL Pharma
7.8.1 SL Pharma Company Summary
7.8.2 SL Pharma Business Overview
7.8.3 SL Pharma Asparaginase Major Product Offerings
7.8.4 SL Pharma Asparaginase Sales and Revenue in Global (2018-2023)
7.8.5 SL Pharma Key News & Latest Developments
7.9 United Biotech
7.9.1 United Biotech Company Summary
7.9.2 United Biotech Business Overview
7.9.3 United Biotech Asparaginase Major Product Offerings
7.9.4 United Biotech Asparaginase Sales and Revenue in Global (2018-2023)
7.9.5 United Biotech Key News & Latest Developments
8 Global Asparaginase Production Capacity, Analysis
8.1 Global Asparaginase Production Capacity, 2018-2029
8.2 Asparaginase Production Capacity of Key Manufacturers in Global Market
8.3 Global Asparaginase Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Asparaginase Supply Chain Analysis
10.1 Asparaginase Industry Value Chain
10.2 Asparaginase Upstream Market
10.3 Asparaginase Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Asparaginase Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ アスパラギナーゼの世界市場見通し2023年-2029年(Asparaginase Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。